Edward Kelly, MD
Family Medicine · Downingtown, PANPI 1235122300
Payments from drug & device makers
Across 515 payments — averaging $16.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$1K
- Pfizer$798
- Novo Nordisk$712
- GSK$638
- Lilly USA, LLC$632
- plus $3K from 39 others
What the payments were for
- Food & beverage$8,512100%
- Education$300%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$8,542 in reported general payments places this provider in the 90th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 22 | $144,080 |
| EliquisApixaban | 233 | $132,894 |
| MounjaroTirzepatide | 54 | $63,109 |
| JardianceEmpagliflozin | 67 | $53,188 |
| Oxymorphone Hcl ErOxymorphone Hcl | 12 | $49,819 |
| OzempicSemaglutide | 37 | $41,285 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 44 | $32,745 |
| XareltoRivaroxaban | 20 | $31,143 |
| FarxigaDapagliflozin Propanediol | 24 | $29,036 |
| OxycontinOxycodone Hcl | 11 | $28,947 |
| JanuviaSitagliptin Phosphate | 39 | $25,661 |
| TrulicityDulaglutide | 13 | $14,397 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 11 | $13,841 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 17 | $13,754 |
| Xultophy 100-3.6Insulin Degludec/Liraglutide | 11 | $13,650 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Abrysvo | $798 | $143,773267 claims |
| Lilly USA, LLCMounjaro, Trulicity | $632 | $77,50767 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Trijardy Xr | $218 | $74,15496 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $1,253 | $67,33487 claims |
| Novo NordiskOzempic, Xultophy 100-3.6 | $712 | $54,93548 claims |
| MerckJanuvia, Janumet Xr | $348 | $39,50250 claims |
| Johnson & JohnsonXarelto | $70 | $31,14320 claims |
| GSKTrelegy Ellipta | $638 | $10,54716 claims |
| AbbVieLinzess | $1,434 | $7,36114 claims |
| Astellas Pharma US IncMyrbetriq | $138 | $7,04716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Downingtown
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.